2Anfuso S, Soncini E, Bonelli P, etal. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience[J].Acta Blomed, Z007, 78 (3) : 214-219.
6Ay E, Kayak ZN, Elter K, etal. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human ehorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy[J]. Aust N Z J Obstet Gynaecol, 2005, 45(4): 283-288.
3Hsu JJ,Hsieh TT,Hsieh FJ.Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG:a report of the Taiwan Down Syndrome Screening Group.Obstet Gynecol,1996; 87:943～947
4Cuckle HS,Wald NJ,Thompson SG.Estimating a woman'srisk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level.Br J Obstet Gynaecol,1987 ;94:387～402
5Chik L,Spencer K,Johnson MP,et al.Precise gaussian distribution functions of maternal serum alpha-fetoprotein and free beta-subunit of human chorionic gonadotropin for trisomy21 screening:improved accuracy for patient counseling.Am J Obstet Gynecol,1997; 177:882～886
6O'Brien WF,Knuppel RA,Torres C,et al.Potential prenatal predictions of Down syndrome:a statistical analysis.Am J Obstet Gynecol,1990; 163:1796～1798
7Hsu JJ,Hsieh TT,Soong YK,et al.Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha -fetoprotein with maternal age.Prenat Diagn,1997;17:707～716
8Spencer K.Screening for Down's syndrome.The role of intact hCG and free subunit measurement.Scand J Clin Lab Invest,1993 ;53:79～96
9孙念估.产前诊断相关问题及讨论[C].第三届全国产前诊断会议,2002:10
10Triple marker screening for trisomy 21,trisomy 18 and open nema tube defects in singleton pregnancies of native Japanese pregnam women[J].Obstet Gynaecol Res,2000,12:26.
2DUGOFF L. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes [J]. Obstet Gynecol, 2010, 115(5):1052-1061.
3D'ANTONIO F, RIJO C, THILAGANATHAN B, et al. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications[J]. Prenat Diagn, 2013,33(9):839-847.
4LAURA J P, REBECCA B, ROBERT C, et al. Association between eclampsia, maternal characteristics, and abnormal levels of first and second trimester serum biomarkers[J]. Reprod Sci, 2014,21(3):297A.
5ODIBO A, ZHONG Y, KATHERINE R, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia[J]. Placenta, 2011,32(8):598-602.
6UCCELLA S, COLOMBO G F, BULGHERONI C M, et al. First-trimester maternal serum screening and the risk for fetal distress during labor [J]. Am J Obstet Gynecol, 2009,201(2):166.e1-6.
7KARIM J N, SAU A. Low pregnancy associated plasma protein-A in the 1st trimester: is it a predictor of poor perinatal outcome?[J]. J Obstet Gynaecol, 2013, 33(4):351-354.
8LAKHI N, GOVIND A, MORETTI M, et al. Maternal serum analytes as markers of adverse obstetric outcome[J]. Obstet Gynecol, 2012,14(4):267-273.
9YUAN W, CHEN L, BERNAL A L. Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2009,145(1):57-64.
10KRAUSE T G, CHRISTENS P, WOHLFAHRT J, et al. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome[J]. Obstet Gynecol, 2001,97(2):277-282.
